PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Takeda signs deal with UK biotech Engitix

Takeda has signed a licensing agreement with UK biotech Engitix to develop new therapies for advanced fibrotic liver diseases, including non-alcoholic steatohepatiti...
Continue Reading →
News

ACG promotes Susheel Pillai as the new CEO for Inspection Business

ACG, a leading supplier of fully integrated solutions to the global pharmaceutical and nutraceutical industry, today announced the promotion of Susheel Pillai as the...
Continue Reading →
News

Europital forecast 30% CAGR from UK biotech for three years

CRO opens new Oxford site in response to urgent demand from small and medium innovators for specialist scientific expertise Ghent (Belgium), 24 August 2020:  Europ...
Continue Reading →
News

EU regulators to review Evrysdi for SMA

EU regulators have agreed to review Roche's Evrysdi (risdiplam) for the treatment of spinal muscular atrophy (SMA), a severe, inherited, progressive neuromuscular di...
Continue Reading →
News

Hancock confirms replacement of Public Health England

Health and Care Secretary Matt Hancock has confirmed that Public Health England (PHE) will be replaced with a new organisation called the National Institute for Heal...
Continue Reading →
News

Gov announces expansion of UK’s ONS COVID-19 survey

Health and Social Care Secretary Matt Hancock has announced plans to expand the Office for National Statistics' (ONS) infection survey to increase insight into the p...
Continue Reading →
News

Priority review for Imfinzi’s less-frequent dosing regimen

AstraZeneca's Imfinzi (durvalumab) has been granted a priority review in the US for a new four-week, fixed-dose regimen for treatment of non-small cell lung cancer (...
Continue Reading →
News

Verona progresses PhII trial of COPD inhaler

Verona Pharma is progressing a Phase II trial of new inhaler formulation of ensifentrine following a coronavirus pandemic-induced pause. The company said it has no...
Continue Reading →
News

Roche’s Enspryng approved for Neuromyelitis Optica Spectrum Disorder

US regulators have approved Roche's Enspryng (satralizumab-mwge) as the first and only subcutaneous treatment for adults living with the rare autoimmune disorder ant...
Continue Reading →
Uncategorised

Eli Lilly, Pieris collaborate on HER2-positive cancer clinical programme

Eli Lilly and Pieris Pharmaceuticals have entered into a clinical trial collaboration and supply agreement to evaluate a combination of candidates in multiple types ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026